Fig. 7
From: Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer
Comparisons of ICDs and ICPs in IS1-2 in the TCGA-BRCA and METABRIC cohorts. a Differentially expressed ICDs in IS1-2 in the TCGA-BRCA cohort. b Differentially expressed ICDs in IS1-2 in the METABRIC cohort. c Differentially expressed ICPs in IS1-2 in the TCGA-BRCA cohort. d Differentially expressed ICPs in IS1-2 in the METABRIC cohort. ns not significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001